Trial Profile
A study investigating pharmacokinetics of oral suspension of Posaconazole in cystic and non-cystic fibrosis lung transplant recipients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2016
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Pharmacokinetics
- 06 Apr 2016 New trial record
- 28 Mar 2016 Results published in the Antimicrobial Agents and Chemotherapy.